• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Relationship between dose and plasma level of digoxin and patient characteristics.

作者信息

Heinz N, Rietbrock N

出版信息

Eur J Clin Pharmacol. 1979 Mar 26;15(2):109-14. doi: 10.1007/BF00609873.

DOI:10.1007/BF00609873
PMID:436919
Abstract

The correlation between the daily dose of digoxin, its plasma level and clinical characteristics of 213 patients receiving beta-acetyldigoxin treatment has been evaluated. After logarithmic transformation of lognormally distributed variables multiple linear regression analysis was performed. Eight predictor variables were chosen: sex, age, height, weight, glycoside dose, creatinine and potassium level in serum and dose of spironolactone. The resulting correlation coefficient was 0.46, i.e. only 100 x r2 = 21.4% of the variance of the steady state digoxin plasma level could be interpreted with the aid of these variables. For only 4 of the 8 variables (age, glycoside dose, serum level of creatinine, and spironolactone dose) were partial coefficients of regression and of correlation significantly different from zero. Almost 80% of the variance could not be accounted for. This finding is in accordance with conclusions in the literature.

摘要

相似文献

1
Relationship between dose and plasma level of digoxin and patient characteristics.
Eur J Clin Pharmacol. 1979 Mar 26;15(2):109-14. doi: 10.1007/BF00609873.
2
[Clinical study on digoxin tablets with high bioavailability (author's transl)].
Arzneimittelforschung. 1979;29(6):961-4.
3
Relationship between plasma concentration and dose of digoxin in patients with and without renal impairment.肾功能正常和受损患者中地高辛的血药浓度与剂量之间的关系。
Circulation. 1978 Dec;58(6):1196-203. doi: 10.1161/01.cir.58.6.1196.
4
Digoxin-interactions in man: spironolactone reduces renal but not biliary digoxin clearance.地高辛在人体中的相互作用:螺内酯降低地高辛的肾脏清除率,但不降低其胆汁清除率。
Eur J Clin Pharmacol. 1992;42(5):481-5. doi: 10.1007/BF00314854.
5
Steady-state concentrations and dosage of digoxin in relation to kidney function in hospitalized patients over 70 years of age.70岁以上住院患者中地高辛的稳态浓度及剂量与肾功能的关系。
J Intern Med. 1991 Mar;229(3):247-51. doi: 10.1111/j.1365-2796.1991.tb00339.x.
6
[Determinants of plasma digoxin and digitoxin concentrations in elderly patients. A multivariate analysis].
Klin Wochenschr. 1987 Nov 16;65(22):1073-80. doi: 10.1007/BF01736113.
7
Clinical studies on digoxin intoxication. I. Serum concentration of digoxin in the elderly and the effect of diuretics.
Jpn Heart J. 1980 May;21(3):341-56.
8
Serum digoxin and beta-methyldigoxin in elderly patients on hospital admission: correlation with home compliance and clinical variables.
Eur J Clin Pharmacol. 1989;37(4):401-4. doi: 10.1007/BF00558509.
9
[Plasma concentrations of digoxin in patients under intensive care conditions and in patients undergoing anesthesia and operation (author' transl)].重症监护患者以及接受麻醉和手术患者的地高辛血浆浓度(作者译)
Klin Wochenschr. 1978 May 15;56(10):503-17. doi: 10.1007/BF01492863.
10
Serum digoxin level - determined or estimated?
Cor Vasa. 1983;25(1):35-41.

引用本文的文献

1
Clinical implications of serum digoxin concentrations.
Klin Wochenschr. 1981 May 15;59(10):501-7. doi: 10.1007/BF01696212.
2
A standard approach to compiling clinical pharmacokinetic data.一种汇编临床药代动力学数据的标准方法。
J Pharmacokinet Biopharm. 1981 Feb;9(1):59-127. doi: 10.1007/BF01059343.
3
Pharmacokinetics of digoxin in pregnancy.
Eur J Clin Pharmacol. 1983;25(1):117-21. doi: 10.1007/BF00544027.

本文引用的文献

1
STUDIES WITH TRITIATED DIGOXIN IN RENAL FAILURE.肾衰竭中氚标记地高辛的研究。
Am J Med. 1964 Oct;37:536-44. doi: 10.1016/0002-9343(64)90067-1.
2
Blood levels of drug at the equilibrium state after multiple dosing.多次给药后达到平衡状态时药物的血药浓度。
Nature. 1965 Sep 18;207(5003):1301-2. doi: 10.1038/2071301a0.
3
An improved method of digoxin therapy.一种改进的地高辛治疗方法。
Ann Intern Med. 1968 Oct;69(4):703-17. doi: 10.7326/0003-4819-69-4-703.
4
Factors that regulate ouabain-H3 accumulation by the isolated guinea-pig heart.
J Pharmacol Exp Ther. 1969 Dec;170(2):318-25.
5
Correlation of plasma levels of digoxin in cardiac patients with dose and measures of renal function.心脏病患者血浆地高辛水平与剂量及肾功能指标的相关性。
Clin Pharmacol Ther. 1974 Mar;15(3):291-301. doi: 10.1002/cpt1974153291.
6
Computer-assisted digoxin therapy.计算机辅助地高辛治疗
N Engl J Med. 1973 Aug 30;289(9):441-6. doi: 10.1056/NEJM197308302890902.
7
[Serum digoxin level and renal function].[血清地高辛水平与肾功能]
Dtsch Med Wochenschr. 1973 Aug 24;98(34):1547-51. doi: 10.1055/s-0028-1107078.
8
Species and ionic influences on the accumulation of digitalis glycosides by isolated perfused hearts.物种和离子对离体灌注心脏中洋地黄苷积累的影响。
Br J Pharmacol. 1972 Nov;46(3):401-8. doi: 10.1111/j.1476-5381.1972.tb08137.x.
9
Instructional goals for physicians in the use of blood level data--and the contribution of computers.
Clin Pharmacol Ther. 1974 Jul;16(1):260-71. doi: 10.1002/cpt1974161part2260.
10
[Elimination kinetics and dosage of digoxin in patients in renal failure (author's transl)].
Dtsch Med Wochenschr. 1974 Sep 13;99(37):1797-803. doi: 10.1055/s-0028-1108049.